Ryohei Ogawa Selected Research

2-amino-4-hydroxy-6-formylpteridine

1/2007	Gene expression in enhanced apoptosis of human lymphoma U937 cells treated with the combination of different free radical generators and hyperthermia.
4/2004	Enhancement of radiation-induced apoptosis by 6-formylpterin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryohei Ogawa Research Topics

Disease

19	Neoplasms (Cancer) 03/2021 - 04/2002
10	Lymphoma (Lymphomas) 07/2016 - 02/2003
8	Hyperthermia 01/2019 - 04/2002
4	Leukemia 12/2018 - 02/2004
4	Prostatic Neoplasms (Prostate Cancer) 07/2013 - 05/2007
2	Malaria 11/2021 - 10/2018
2	Hypoxia (Hypoxemia) 08/2015 - 05/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2014 - 01/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2009 - 06/2003
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2002 - 01/2002
1	Necrosis 03/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Myeloid Leukemia (Leukemia, Myelocytic) 02/2018
1	Osteosarcoma (Osteogenic Sarcoma) 06/2010
1	Sarcoma (Soft Tissue Sarcoma) 01/2010
1	Muscle Hypotonia (Hypotonia) 01/2010
1	Colonic Neoplasms (Colon Cancer) 01/2010
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2006

Drug/Important Bio-Agent (IBA)

6	LuciferasesIBA 03/2021 - 05/2007
4	Pharmaceutical PreparationsIBA 01/2019 - 06/2009
4	CaspasesIBA 05/2014 - 05/2002
4	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2006
3	SuspensionsIBA 01/2010 - 04/2002
3	Complementary DNA (cDNA)IBA 01/2009 - 03/2006
3	SHU 508 (Levovist)IBA 06/2008 - 02/2003
3	Free RadicalsIBA 01/2007 - 06/2003
3	2,2'-azobis(2-amidinopropane) (ABAP)IBA 01/2007 - 06/2003
2	SolutionsIBA 12/2018 - 02/2004
2	CadmiumIBA 02/2018 - 12/2011
2	Docosahexaenoic AcidsIBA 08/2015 - 05/2014
2	Transcription Factors (Transcription Factor)IBA 07/2013 - 01/2013
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 06/2010 - 01/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 01/2010
2	LigandsIBA 06/2010 - 01/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2009 - 04/2008
2	2-amino-4-hydroxy-6-formylpteridineIBA 01/2007 - 04/2004
2	Contrast MediaIBA 10/2006 - 02/2003
1	Biological ProductsIBA 11/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2019
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2019
1	Glutathione (Reduced Glutathione)IBA 12/2018
1	hydroxide ionIBA 12/2018
1	Cystine (L-Cystine)IBA 12/2018
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 12/2018
1	AntiportersIBA 12/2018
1	Glutamic Acid (Glutamate)FDA Link 12/2018
1	VaccinesIBA 10/2018
1	PlatinumIBA 07/2016
1	tempolIBA 08/2015
1	Oxygen (Dioxygen)IBA 08/2015
1	nitroxylIBA 08/2015
1	Small Interfering RNA (siRNA)IBA 05/2015
1	Protein Kinase CIBA 05/2014
1	nutlin 3IBA 01/2010
1	Heme Oxygenase-1IBA 01/2009
1	phenyl-N-tert-butylnitroneIBA 01/2007
1	Liposomes (Liposome)IBA 10/2006
1	Trypan Blue FDA Link 03/2006
1	Messenger RNA (mRNA)IBA 03/2006
1	Coloring Agents (Dyes)IBA 03/2006
1	Epstein-Barr Virus Nuclear AntigensIBA 01/2006
1	EBV-encoded nuclear antigen 1IBA 01/2006
1	chromium hexavalent ionIBA 06/2004
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2004
1	Phosphates (Orthophosphate)IBA 02/2004
1	Cytochromes c (Cytochrome c)IBA 06/2003
1	FS 069 (Optison)FDA Link 02/2003
1	Local AnestheticsIBA 05/2002
1	Lidocaine (Xylocaine)FDA LinkGeneric 05/2002
1	Superoxides (Superoxide)IBA 05/2002
1	Adenosine Triphosphate (ATP)IBA 05/2002
1	Caspase 3 (Caspase-3)IBA 05/2002

Therapy/Procedure

13	Therapeutics 03/2021 - 04/2002
5	Induced Hyperthermia (Thermotherapy) 05/2014 - 04/2002
1	Radiotherapy 05/2015
1	Drug Therapy (Chemotherapy) 06/2010
1	Microbubbles 06/2008